Could TB treatment be cut from 6 months to 8 weeks? major trial launches

NCT ID NCT06114628

Recruiting now Disease control Sponsor: University College, London Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests new drug combinations to treat pulmonary tuberculosis (TB) faster than the standard 24-week regimen. About 2500 adults with TB will receive one of several experimental combinations, including two new drugs (BTZ-043 and GSK3036656), for 8 to 16 weeks. Researchers aim to find a shorter, equally safe and effective treatment that could also work for drug-resistant TB.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulmonary tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PULMONARY TUBERCULOSIS

Contacts and locations

Locations

Joint Clinical Research Centre
RECRUITING

Kampala, Uganda
Kibong'oto Infectious Diseases Hospital
RECRUITING

Moshi, Tanzania
Makerere University Lung Institute
RECRUITING

Kampala, Uganda
NIMR Mbeya
RECRUITING

Mbeya, Tanzania
NIMR Mwanza
RECRUITING

Mwanza, Tanzania
National Lung Hospital
ACTIVE_NOT_RECRUITING

Hanoi, Vietnam
PMSI Institute of Pneumology "Chiril Draganiuc"
ACTIVE_NOT_RECRUITING

Chisinau, Moldova
Pnth/Oucru
ACTIVE_NOT_RECRUITING

Ho Chi Minh City, Vietnam
TASK Brooklyn
RECRUITING

Cape Town, South Africa
TASK Eden
RECRUITING

George, South Africa
University of Cape Town Lung Institute
RECRUITING

Cape Town, South Africa

More trials for these conditions

Other studies related to the condition(s) this trial covers.